文献速递运动医学关节外科

关节镜下上关节囊重建术后患者可接受症状状态、最小临床重要差异与实质临床获益

Patient Acceptable Symptom State, Minimal Clinically Important Difference, and Substantial Clinical Benefit After Arthroscopic Superior Capsular Reconstruction.
PubMed 文献 · Am J Sports Med · 2022-08-30

回顾性队列纳入2013年6月至2020年10月接受阔筋膜自体移植关节镜下上关节囊重建(ASCR)的88例患者,术后至少1年随访时以锚定问题推导pVAS、ASES评分、Constant评分和SANE的PASS、MCID与SCB值,并分析达成这些阈值的相关因素;四种评分的曲线下面积均>0.7。

要点

  • ASCR术后至少1年时pVAS的PASS、MCID、SCB分别为1.5、2.5、4.5。
  • ASES评分对应值分别为81.0、19.0、27.5;Constant评分为60.5、-0.5、5.5;SANDE为75.0、27.5、32.5。
  • 术前评分差与达成MCID和SCB的OR显著更高相关;肩胛下肌撕裂与pVAS的PASS及Constant评分的SCB达成OR更低相关。

核心结论

  • ASCR术后至少1年可获得可靠的PASS、MCID和SCB值。
  • 术前评分差、肩峰肱骨距离宽和优势侧与至少一项阈值达成OR更高相关,肩胛下肌撕裂与pVAS的PASS及Constant评分的SCB达成OR更低相关。

研究设计与样本

  • 回顾性队列研究(诊断性),证据等级2级,纳入2013年6月至2020年10月接受阔筋膜自体移植ASCR的88例患者,术后至少1年随访时应用锚定问题。
  • 采用基于敏感度和特异度的方法推导PASS、MCID和SCB值,并行单因素和多因素logistic回归分析达成这些阈值的因素。

主要发现

  • 受试者工作特征曲线显示四种评分对PASS、MCID和SCB的曲线下面积均>0.7。
  • pVAS的PASS、MCID、SCB分别为1.5、2.5、4.5;ASES评分分别为81.0、19.0、27.5;Constant评分分别为60.5、-0.5、5.5;SANE分别为75.0、27.5、32.5。
  • 术前评分差与达成MCID和SCB的OR显著更高相关。
  • 肩峰肱骨距离宽和优势侧与ASES评分达成PASS的OR更高相关。
  • 肩胛下肌撕裂与pVAS达成PASS及Constant评分达成SCB的OR更低相关。

关键数值与推荐

  • pVAS的PASS为1.5、MCID为2.5、SCB为4.5。
  • ASES评分的PASS为81.0、MCID为19.0、SCB为27.5。
  • Constant评分的PASS为60.5、MCID为-0.5、SCB为5.5。
  • SANE的PASS为75.0、MCID为27.5、SCB为32.5。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient Acceptable Symptom State (PASS), minimal clinically important difference (MCID), and substantial clinical benefit (SCB) have rarely been assessed after arthroscopic superior capsular reconstruction (ASCR) with fascia lata autograft. PURPOSE: (1) To investigate PASS, MCID, and SCB values for pain visual analog scale (pVAS), American Shoulder and Elbow Surgeons (ASES) score, Constant score, and Single Assessment Numeric Evaluation (SANE) after ASCR with fascia lata autograft, (2) to investigate factors for achieving PASS, MCID, and SCB. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 2. METHODS: We retrospectively collected data from patients who underwent ASCR between June 2013 and October 2020. A total of 88 patients were included, and anchor questions for deriving PASS, MCID, and SCB values were applied at a minimum 1-year follow-up postoperatively. PASS, MCID, and SCB were derived using sensitivity- and specificity-based approaches. Univariable and multivariable logistic regression analyses were performed to determine factors for achieving PASS, MCID, and SCB. RESULTS: Based on receiver operating characteristic curves, all 4 scores had acceptable area under the curve values (>0.7) for PASS, MCID, and SCB values. The PASS, MCID, and SCB values were 1.5, 2.5, and 4.5 for pVAS; 81.0, 19.0, and 27.5 for the ASES score; 60.5, -0.5, and 5.5 for the Constant score; and 75.0, 27.5, and 32.5 for SANE, respectively. Poor preoperative scores were related to significantly higher odds ratios (ORs) for achieving MCID and SCB. Wide acromiohumeral distance and dominant side were related to higher ORs for achieving PASS for the ASES score, and subscapularis tear was related to lower ORs for achieving PASS for pVAS and SCB for the Constant score. CONCLUSION: Reliable PASS, MCID, and SCB values were achieved for at least 1 year after ASCR surgery. Poor preoperative score, wide acromiohumeral distance, and dominant side all demonstrated higher ORs for at least one value, but a subscapularis tear demonstrated lower ORs for achieving PASS for pVAS and SCB for the Constant score.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Yeom JW, Kim DM, Lee JB, et al. Patient Acceptable Symptom State, Minimal Clinically Important Difference, and Substantial Clinical Benefit After Arthroscopic Superior Capsular Reconstruction. Am J Sports Med. 2022. PMID: 36041050. doi:10.1177/03635465221118582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。